Zevra Therapeutics, Inc.ZVRANASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average.
Left:
||||
Price-to-book ratio
Latest
9.72
↑ 6599% above average
Average (9y)
-0.15
Historical baseline
Range
High:9.72
Low:-14.46
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 9.72 | +159.1% |
| 2023 | 3.75 | +78.1% |
| 2022 | 2.11 | +3.3% |
| 2021 | 2.04 | +403.8% |
| 2020 | -0.67 | -344.8% |
| 2019 | -0.15 | +68.5% |
| 2018 | -0.48 | +54.7% |
| 2017 | -1.06 | +54.1% |
| 2016 | -2.30 | +84.1% |
| 2015 | -14.46 | - |